Ameriprise reports 18% Synaptics stake in 13G/A
Ameriprise Financial, Inc., through its investment adviser Columbia Management Investment Advisers and related funds, filed an amended Schedule 13G reporting significant ownership of Synaptics Incorporated common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Ameriprise Financial, Inc., through its investment adviser Columbia Management Investment Advisers and related funds, filed an amended Schedule 13G reporting significant ownership of Synaptics Incorporated common stock. As of December 31, 2025, Ameriprise is deemed to beneficially own 7,021,238 shares, or 18.0% of the class, primarily via Columbia-managed funds. The Columbia Seligman Technology and Information Fund separately reports beneficial ownership of 4,279,098 shares, representing 11.0% of the outstanding common stock. The filers state the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Synaptics.
Insights
Large institutional holders report up to 18% of Synaptics, with a passive intent statement.
Ameriprise Financial and its investment adviser report beneficial ownership of 7,021,238 Synaptics shares, or 18.0% of the common stock as of December 31, 2025. The Columbia Seligman Technology and Information Fund alone reports 4,279,098 shares, or 11.0%.
The filing clarifies that Columbia Management Investment Advisers may be deemed to beneficially own shares held across various funds and accounts, and Ameriprise may be deemed to own those held by Columbia. Each entity disclaims beneficial ownership, signalling that legal control and economic exposure are structured through advisory relationships.
The certification states the securities were acquired and are held in the ordinary course of business and not to change or influence control of Synaptics. Future ownership levels will depend on portfolio decisions within Columbia-managed funds and accounts, but this document presents the position as a passive institutional holding at year-end 2025.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How much of Synaptics (SYNA) does Ameriprise Financial beneficially own?
What stake does Columbia Seligman Technology and Information Fund hold in Synaptics (SYNA)?
Is Ameriprise’s Synaptics (SYNA) position intended to influence control of the company?
Which entities are reporting beneficial ownership of Synaptics (SYNA) in this Schedule 13G/A?
AI-generated analysis. How Rhea-AI works. Not financial advice.